Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Revenue: 2020-2025

Historic Revenue for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $239.5 million.

  • Harmony Biosciences Holdings' Revenue rose 28.71% to $239.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $825.9 million, marking a year-over-year increase of 21.13%. This contributed to the annual value of $714.7 million for FY2024, which is 22.80% up from last year.
  • Harmony Biosciences Holdings' Revenue amounted to $239.5 million in Q3 2025, which was up 19.44% from $200.5 million recorded in Q2 2025.
  • Over the past 5 years, Harmony Biosciences Holdings' Revenue peaked at $239.5 million during Q3 2025, and registered a low of $59.7 million during Q1 2021.
  • For the 3-year period, Harmony Biosciences Holdings' Revenue averaged around $174.7 million, with its median value being $172.8 million (2024).
  • Data for Harmony Biosciences Holdings' Revenue shows a peak YoY soared of 200.78% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Harmony Biosciences Holdings' Revenue stood at $91.2 million in 2021, then soared by 40.67% to $128.3 million in 2022, then surged by 31.26% to $168.4 million in 2023, then increased by 19.51% to $201.3 million in 2024, then rose by 28.71% to $239.5 million in 2025.
  • Its last three reported values are $239.5 million in Q3 2025, $200.5 million for Q2 2025, and $184.7 million during Q1 2025.